semaglutide st john in Realities of life on GLP-1s

Still, FDA approval of the Wegovy pill could prove financially favorable for Novo Nordisk, which has faced numerous challenges in 2025, including disappointing results from its clinical trial of semaglutide as a treatment for Alzheimers.

Slowed aging associated with the risk of allcause mortality in 34% of participants as measured by the PCGrimAge epigenetic clock

While serious liver damage from semaglutide is not a commonly recognized adverse effect, patients and healthcare providers should remain vigilant for signs and symptoms that could indicate hepatic dysfunction

Current evidence from animal studies has raised questions about possible risks, though human data remains limited

Blood pressure reduction Blood pressure decreases gradually over the first six months